About Project Shivom

Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.

The researchers and experts in healthcare industry found that genomic data can enhance the understanding and find the treatment of more than 7000 diseases which is not yet found in the market. It has also proved beneficial for cancer and longterm diseases like cardiovascular. The Shivom is boon for those patients who are suffering from diseases. It is a blockchain based venture which will create a platform for genomics. The platform is beneficial to all pharmaceuticals, research organization, government, insurance company etc. It is fully decentralized creating an opportunity for the healthcare market by introducing more open, fair and safe environment. The best part about this ico is that user will be able to maintain its own genome data and also has right to share in the market. The platform is next evolutionary step in the healthcare market creating more and more opportunities for the future marketplace.

The Shivom ecosystem

Shivom is creating a genomics ecosystem on the blockchain. We will offer an open marketplace for healthcare providers to add their apps and services, alongside genomic data analytics and personalized medicine.

Transform genomic data into useable informationg
Break down data silos
Help accelerate clinical trials
Facilitate drug research and development
Sponsor sequencing projects to get access to relevant data

Features of the Shivom

The Shivom technology will be transferring the genomic data into usable information. The parameters will be decided to record the information as per the industry standard.

The recorded data will be broken down into the small pieces. It will be separated and listed as per the requirement of the medical industry so that the process will become easy.

The smart data will help to accelerate the clinical trials. The medical institute will receive the exact information that they need for the clinical trials. It will save time which generally invested in the research and finding the right information for the process.

The stored data is gold for the medical industry. The top medical research institute from all around the world can use the data to do the research on the various diseases. A large amount of data will help them to understand the cause of certain diseases. It will facilitate the research and development of the drug.

The Shivom platform will provide the access to the sponsor to access the relevant data for their projects. It will be widely shared and provided to the research institute to develop the drugs that will help the human kind to survive in the difficult situation.

OmiX Token Attributes
The OmiX tokens hold an important role in the governance of the system for two main reasons. First, it serves as the fuel of the platform operation. Buying, trading, rewarding, and other transactions will use this token. That is why OmiX token is the key component for Shivom.

As a utility token, it holds numerous functions. First, you can use it to get premium services on the Shivom platform. For example, you can get genome sequencing kits by using this utility token. Patients and other users as well can get access to fitness applications provided by the third party with OmiX tokens. These service providers can also use Shivom platform. It is because Shivom is building partnerships to enhance the services. Lastly, yet the most obvious one, the tokens enable the users to access the genome database. Meanwhile, the tokens also enable stakeholders to sponsor the sequencing projects. The tokens are also used by researchers to pay their participants and donors to be involved in their research studies.

OmiX Token Distribution

Shivom already created 3 billion OmiX tokens. This amount of token will be distributed for at least six occasions or parties. 990 million of them will be put on the ICO sale. Meanwhile 90 million of the tokens will be dedicated to the Shivom community. They will be used for rewards and bounty programs. Bounty programs are conducted to influence the network impacts. In other words, this part of the tokens will be utilized to maintain the growth of the community within the platform. Founders will get 420 million of the tokens while advisors will get 300 million tokens. 600 million OmiX tokens will be used for developing the smart contract and other things related growth pool intensification. The rest of the tokens will be reserved by the company.

The funds obtained from the sale will be used for platform development that includes adding new features, curating data, and integrating UI, APIs, and sort of. Other parts of the funds will be used for operations, R&D, marketing, and building partnership.

Roadmap
December, 2016
Conceptualization healthcare ecosystem initiated.
August, 2017
Seed round of $250k finished.
October, 2017
Start of global roadshow.
March, 2018
Whitepaper released.
April, 2018
OmiX token sale starts.
Q1-Q2 2018
Shivom foundation established. Foundation director and first steering committee members on board.
Q1, 2018
Partnership major crypto vc.
April, 2018
Partnership medical center. Collaboration with first of many large clinical centers.Project gaia started. Sequencing project in rural India commenced. Platform alpha release.
Q2, 2018
Partnership major data analytics firm. Co -development to connect Shivom platform with stat-of-the art data analytics pipeline. Pharma partner on board. Collaboration with Top 25 pharmaceutical company.
Q2-Q3, 2018
Web marketplace open.
Q3-Q4, 2018
Formation R&D unit. Official start of global not-forprofit pharmaceutical spin-of. Worldwide rollout of Shivom platform. Shivom services are available on a global scale on all continents.
Q4, 2018
First rare- disease subset. Set of large group of people sequenced with rare disease. First genomics service unit opens. First genomics counseling service unit opens.
Q4 2018 - Q1 2019
Multi-omics integration. A.I. platform. Implementation of artificial intelligence, deep learning platform.